Study of Bimatoprost Solution in Increasing Eyelash Prominence in African Americans With Eyelash Hypotrichosis

Study Identifier
192024-039
CT.gov Identifier
NCT00958035
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Hypotrichosis
    • Study Drug
  • bimatoprost ophthalmic 0.03% solution
  • vehicle sterile solution (placebo)
    • Phase
    Phase 4
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * African American/ethnic black * Adults at least 18 years of age * Eyelash prominence assessment of minimal or moderate
    Exclusion Criteria:
    * Subjects with uneven lashes or longer on one side than the other * Any eye disease or abnormality * Eye surgery * Severe hyperpigmentation around the eye * Eyelash implants * Eyelash extension application * Any use of eyelash growth products within 6 months * Any use of prescription eyelash growth products * Treatments that may affect hair growth * Requiring eye drop medications for glaucoma

    Protocol Summary

    This study will evaluate the safety and efficacy of bimatoprost solution 0.03% once daily to the upper eyelid margins (where the eyelashes meet the skin) compared with vehicle in increasing overall eyelash prominence in self-identified African American/ethnic black subjects exhibiting hypotrichosis of the eyelashes (inadequate or not enough eyelashes).

    Study Locations

    Location
    Status
    Location
    Philadelphia, Pennsylvania, United States
    Status
    Not applicable